Leading UK Pharmacies trust Deltera
The DTP (3-in-1) booster PGD is a core component of travel health. Deltera streamlines this high-volume service, automating the GP notification and ensuring the patient’s booster history is digitally archived.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
It is typically required every 10 years for travel to certain regions or for post-exposure tetanus management. Deltera’s system helps verify the patient's last booster date.
It is a combined booster for Diphtheria, Tetanus, and Polio (Revaxis). Deltera’s portal provides the patient with clear advice on the protection they have received.
While used for travel, it is also applicable for clean tetanus-prone wounds. Our IP Bridge allows for prescriptions if the specific PGD criteria for the wound type are complex.
By automating the GP notification and providing a ready-made report for head office, Deltera removes the "paper tax" associated with this common travel service.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
